Study finds new molecular pathways involved with autoimmune diseases, potential implications for therapies

September 28, 2012
Study finds new molecular pathways involved with autoimmune diseases, potential implications for therapies
Different arrangement of the IRF-4 (blue)/BATF-JunB (red) complex in different promoter sites leads to the activation of the Ctla-4 receptor and Bcl11b gene expression respectively. Credit: Carlos Escalante, Ph.D./VCU

Teamwork between a pair of transcription factors may be responsible for regulating the functioning of Th17 cells, which when found in excessive amounts are believed to play a major role in many autoimmune diseases, according to a study published last week in the journal Science by a national team of researchers.

The findings may help researchers develop potential therapies against autoimmune disease such as multiple sclerosis, psoriasis, , rheumatoid arthritis and .

The collaborative study was led by researchers at Genetech, Inc., in San Francisco, and included researchers from the Virginia Commonwealth University School of Medicine, the Howard Hughes Medical Institute in Chevy Chase, Md., the Washington University School of Medicine in St. Louis, the University of Chicago, New York University and the M.D. Anderson Cancer Center in Houston.

The team reported on new composite DNA sites that included binding sites for both IRF4 and BATF. The composite sites had variations in the spacing separating the two individual sites leading to different arrangement of the two . Transcription factors serve as traffic coordinators, controlling the flow of genetic information from DNA to mRNA.

The study shows that this different arrangement leads to the activation of different genes. Activation of several genes during differentiation of Th17 cells is promoted by the partnership of IRF4 and BATF.

"The work shows for the first time that the transcription factors IRF4 and BATF through cooperative binding to composite DNA sites are critical for the differentiation of T helper 17 cells," said study contributor Carlos R. Escalante, Ph.D., assistant professor in the Department of Physiology and Biophysics in the VCU School of Medicine. Escalante was involved in the generation of the atomic models of the different IRF4-BATF-DNA complexes.

Explore further: Mouse pancreatic stem cells successfully differentiate into insulin producing cells

Related Stories

Recommended for you

Snapshot turns T cell immunology on its head

October 6, 2015

Challenging a universally accepted, longstanding consensus in the field of immunity requires hard evidence. New research from the Australian Research Council Centre of excellence in advanced Molecular imaging has shown the ...

Four gut bacteria decrease asthma risk in infants

September 30, 2015

New research by scientists at UBC and BC Children's Hospital finds that infants can be protected from getting asthma if they acquire four types of gut bacteria by three months of age. More than 300 families from across Canada ...

Flu infection reveals many paths to immune response

September 28, 2015

A new study of influenza infection in an animal model broadens understanding of how the immune system responds to flu virus, showing that the process is more dynamic than usually described, engaging a broader array of biological ...

Immune cells may help fight against obesity

September 15, 2015

While a healthy lifestyle and "good genes" are known to help prevent obesity, new research published on September 15 in Immunity indicates that certain aspects of the immune system may also play an important role. In the ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.